Related Experiment Video
Updated: Feb 26, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Sequential likelihood ratios and e-processes in the analysis of the RENOVATE trial
Fernando G Zampieri1,2, Alexandre B Cavalcanti1, Peter M B Cahusac3
1Research Institute, Hospital do Coracao (HCor), Sao Paulo, Brazil.
Adaptive platform trials can yield misleading results due to changing patient populations. Evidential methods reveal true treatment effects and enrollment dynamics, offering a diagnostic tool for complex trial designs.
Area of Science:
- Clinical Trials
- Biostatistics
- Evidence Synthesis
Background:
- Adaptive platform trials face challenges with heterogeneous populations and non-concurrent enrollment.
- Pooled analyses in such trials can be misleading due to shifting patient composition over time.
Purpose of the Study:
- To quantify treatment effect heterogeneity in the RENOVATE trial using evidential methods and e-processes.
- To demonstrate how temporal shifts in enrollment composition create statistical artifacts in sequential monitoring.
Main Methods:
- Secondary analysis of the RENOVATE trial (n=1,766) comparing high-flow nasal oxygen (HFNO) vs. noninvasive ventilation (NIV) across five populations.
- Computed sequential likelihood ratio (SLR) processes within groups for death or intubation at 7 days.
- Sensitivity analyses used conditional and randomization-based e-processes.
Main Results:
- Substantial treatment effect heterogeneity observed across populations; cardiogenic edema showed HFNO benefit, while COVID-19 suggested potential harm.
- Pooled SLR analysis exhibited a V-shaped artifact due to enrollment composition shifts, particularly during the COVID-19 period.
- Alternative analyses aligned with SLR but avoided artifact interpretation.
Conclusions:
- Sequential evidential analysis effectively reveals treatment heterogeneity masked by pooled analyses in adaptive platform trials.
- Enrollment composition mechanistically drives evidence accumulation trajectories.
- E-processes serve as a diagnostic tool for platform trials, visualizing interactions between enrollment dynamics and treatment heterogeneity.
More Related Videos
10:46A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Related Concept Videos
Odds Ratio
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Comparing the Survival Analysis of Two or More Groups
Testing a Claim about Population Proportion
There are two methods of testing a claim about a population proportion: (1) Using the sample proportion from the data where a binomial distribution is approximated to the normal distribution and (2) Using the binomial probabilities calculated from the data.
The first method uses normal distribution as an approximation to the binomial distribution. The requirements are as follows: sample size is large...
Significance Testing: Overview
Relative Risk